73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Study finds worsening metabolic syndrome increases the risk of developing cancer

Study finds worsening metabolic syndrome increases the risk of developing cancer

by WileyCredit: Pavel Danilyuk from PexelsNew research indicates that individuals with persistent and worsening metabolic syndrome—which encompasses conditions such as high blood pressure, elevat

Study finds worsening metabolic syndrome increases the risk of developing cancer

by WileyCredit: Pavel Danilyuk from PexelsNew research indicates that individuals with persistent and worsening metabolic syndrome—which encompasses conditions such as high blood pressure, elevat
Study shows novel agent can overcome immune dysfunction in cancer

Study shows novel agent can overcome immune dysfunction in cancer

by Roswell Park Comprehensive Cancer CenterVSSP restores myeloid cell frequencies following leukopenia. C57BL/6 mice were injected with CY (200 mg/kg body weight, i.p.) and with two consecutive daily

Study shows novel agent can overcome immune dysfunction in cancer

by Roswell Park Comprehensive Cancer CenterVSSP restores myeloid cell frequencies following leukopenia. C57BL/6 mice were injected with CY (200 mg/kg body weight, i.p.) and with two consecutive daily
Long-term cardiomyopathy risk varies by chemo agent

Long-term cardiomyopathy risk varies by chemo agent

(HealthDay)—Long-term cardiomyopathy risk varies by chemotherapy agent for childhood cancer survivors, with a decreased risk for daunorubicin versus doxorubicin, according to a study recently publishe

Long-term cardiomyopathy risk varies by chemo agent

(HealthDay)—Long-term cardiomyopathy risk varies by chemotherapy agent for childhood cancer survivors, with a decreased risk for daunorubicin versus doxorubicin, according to a study recently publishe
Technology holds personalised cancer vaccine breakthrough

Technology holds personalised cancer vaccine breakthrough

by Kate Zischke,University of QueenslandThe attack of a tumour cell made by white blood cells of the patient (lymphocytes) generated by cancer vaccines. Credit: University of QueenslandUniversit

Technology holds personalised cancer vaccine breakthrough

by Kate Zischke,University of QueenslandThe attack of a tumour cell made by white blood cells of the patient (lymphocytes) generated by cancer vaccines. Credit: University of QueenslandUniversit
Researcher: Big data, networks identify cell signaling pathways in lung cancer

Researcher: Big data, networks identify cell signaling pathways in lung cancer

by University of MontanaThe cover of the May 22 issue ofScience Signalingfeatures a three-dimensional representation of lung cancer protein modifications produced by the machine learn

Researcher: Big data, networks identify cell signaling pathways in lung cancer

by University of MontanaThe cover of the May 22 issue ofScience Signalingfeatures a three-dimensional representation of lung cancer protein modifications produced by the machine learn
Types of bacteria vary widely in tumors of people with early vs. late-onset colorectal cancer

Types of bacteria vary widely in tumors of people with early vs. late-onset colorectal cancer

by Georgetown University Medical CenterCredit: Pixabay/CC0 Public DomainResearchers at Georgetown University's Lombardi Comprehensive Cancer Center studied the microbiome of people with color

Types of bacteria vary widely in tumors of people with early vs. late-onset colorectal cancer

by Georgetown University Medical CenterCredit: Pixabay/CC0 Public DomainResearchers at Georgetown University's Lombardi Comprehensive Cancer Center studied the microbiome of people with color
Second primary malignancies represent small proportion of adverse events after CAR T-cell therapy

Second primary malignancies represent small proportion of adverse events after CAR T-cell therapy

by Elana GotkineSecond primary malignancies (SPMs) represent a small proportion of adverse events (AEs) reported by patients receiving chimeric antigen receptor T-cell (CAR T-cell) therapy, according

Second primary malignancies represent small proportion of adverse events after CAR T-cell therapy

by Elana GotkineSecond primary malignancies (SPMs) represent a small proportion of adverse events (AEs) reported by patients receiving chimeric antigen receptor T-cell (CAR T-cell) therapy, according
Key human bladder cancer genes pinpointed in cats and dogs

Key human bladder cancer genes pinpointed in cats and dogs

by Wellcome Trust Sanger InstituteCredit: Unsplash/CC0 Public DomainKey bladder cancer genes have been uncovered through studying the cancers in cats and dogs, in a significant stride for finding

Key human bladder cancer genes pinpointed in cats and dogs

by Wellcome Trust Sanger InstituteCredit: Unsplash/CC0 Public DomainKey bladder cancer genes have been uncovered through studying the cancers in cats and dogs, in a significant stride for finding
New study suggests way to predict outcomes with high accuracy prior to surgery for pancreatic cancer patients

New study suggests way to predict outcomes with high accuracy prior to surgery for pancreatic cancer patients

by National Comprehensive Cancer NetworkPancreatic cancer cells (blue) growing as a sphere encased in membranes (red). Credit: National Cancer InstituteNew research in the September 2022 issue of&nbsp

New study suggests way to predict outcomes with high accuracy prior to surgery for pancreatic cancer patients

by National Comprehensive Cancer NetworkPancreatic cancer cells (blue) growing as a sphere encased in membranes (red). Credit: National Cancer InstituteNew research in the September 2022 issue of&nbsp
Potential probe for early ovarian cancer

Potential probe for early ovarian cancer

by Anivarya Kumar,Vanderbilt UniversityFigure 1. (a) Structure of COX-2-selective inhibitors (celecoxib, rofecoxib, and valdecoxib) and COX-1-selective inhibitors (SC560, P6/18F-P6, and VU048783

Potential probe for early ovarian cancer

by Anivarya Kumar,Vanderbilt UniversityFigure 1. (a) Structure of COX-2-selective inhibitors (celecoxib, rofecoxib, and valdecoxib) and COX-1-selective inhibitors (SC560, P6/18F-P6, and VU048783
Second opinions from comprehensive cancer centers changed treatment plans for African-American patients

Second opinions from comprehensive cancer centers changed treatment plans for African-American patients

by American Association for Cancer ResearchCancer cell during cell division. Credit: National Institutes of HealthAfrican American breast cancer patients who received second opinions from an NCI-

Second opinions from comprehensive cancer centers changed treatment plans for African-American patients

by American Association for Cancer ResearchCancer cell during cell division. Credit: National Institutes of HealthAfrican American breast cancer patients who received second opinions from an NCI-
Continued access to fertility preservation is critical for teens and young adult cancer patients after SCOTUS decision

Continued access to fertility preservation is critical for teens and young adult cancer patients after SCOTUS decision

by American Cancer SocietyCredit: Pixabay/CC0 Public DomainThe Supreme Court of the United States (SCOTUS) ruling in Dobbs vs. Jackson overruled Roe vs. Wade, returning an individual's right

Continued access to fertility preservation is critical for teens and young adult cancer patients after SCOTUS decision

by American Cancer SocietyCredit: Pixabay/CC0 Public DomainThe Supreme Court of the United States (SCOTUS) ruling in Dobbs vs. Jackson overruled Roe vs. Wade, returning an individual's right